Hafeez Rahman Selected Research

salicylurate (salicyluric acid)

1/2020

ASA Suppresses PGE2 in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hafeez Rahman Research Topics

Disease

4	Melanoma (Melanoma, Malignant) 01/2022 - 10/2018
2	Nevus (Nevi) 01/2022 - 01/2020
2	Pigmented Nevus (Melanocytic Nevus) 01/2022 - 01/2020
1	Carcinogenesis 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Sunburn 01/2021
1	Neoplasms (Cancer) 10/2018

Drug/Important Bio-Agent (IBA)

4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 10/2018
4	Dinoprostone (PGE2)FDA Link 01/2022 - 10/2018
2	8-hydroxyguanineIBA 01/2022 - 01/2021
2	Pyrimidine DimersIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2018
1	CytokinesIBA 01/2020
1	Anticarcinogenic AgentsIBA 01/2020
1	2,5-dihydroxybenzoic acid (gentisic acid)IBA 01/2020
1	salicylurate (salicyluric acid)IBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	SalicylatesIBA 01/2020
1	Melanins (Melanin)IBA 10/2018
1	Adenylate KinaseIBA 10/2018
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2018
1	Celecoxib (Celebrex)FDA Link 10/2018

Therapy/Procedure

2	Chemoprevention 01/2020 - 10/2018